Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Context Safe and effective strategies to curb rising obesity prevalence rates are urgently needed and medications may play a more prominent role in future therapeutic regimens. Objective To review systematically the long-term efficacy and safety of approved antiobesity medications. Data sources MEDLINE, EMBASE, the Cochrane Controlled Trials Register, Current Science Meta-register of Controlled Trials, and reference lists of original studies and reviews were searched. Drug manufacturers and two obesity experts were contacted. No language restrictions were imposed. Study selection Double-blind, randomized controlled studies of approved antiobesity medications with follow-up periods of 1 y or greater were eligible for inclusion. Data extraction Two reviewers independently assessed all potentially relevant studies for inclusion and methodological quality using standardized abstraction forms. Results A total of 11orlistat (n=6021) and three sibutramine (n=929) studies met inclusion criteria. Attrition rates averaged 33% in orlistat studies and 48% in sibutramine studies. A random effects model was used for meta-analysis. Compared to placebo, orlistat-treated patients displayed a 2.7 kg (95% CI: 2.3-3.1 kg) or 2.9% (95% CI: 2.3-3.4%) greater reduction in weight and patients on sibutramine displayed a 4.3 kg (95% CI: 3.6-4.9 kg) or 4.6% (95% CI: 3.8-5.4%) greater weight reduction after 1 y of follow-up. The number of patients achieving 10% or greater weight loss was 12% (95% CI: 8-…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pancreatic lipase inhibitor, orlistat blocks dietary fat absorption, resulting in ~3–5% weight loss.”
From Obesity: Clinical Impact, Pathophysiology, Complications, and Modern Innovations in Therapeutic Strategies (2025) · cites this paper as [57]
Citations
Cites
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
(1998) · PsycEXTRA Dataset · doi:10.1037/e565682010-001 · Cited by 9,472
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Moher, D., Cook, D. J., Eastwood, S., Olkin, I., Rennie, D., & Stroup, D. F. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04149-5 · Cited by 4,826
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
Cited by
Items 301–351 of 351
Aziz, A. A., & Anderson, G. H. (2005) · CRC Press eBooks · doi:10.1201/9781420038255-16 · Cited by 1
Eating Disorders and Obesity: How Drugs Can Help
Silverstone, T. (2005) · Cited by 4
A importância da motivação no tratamento da obesidade em jovens e adultos
Mestre, S. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/dnkv-gk95 · Cited by 2
Therapeutic Aspects of Polycystic Ovary Syndrome in Adolescence
Koliopoulos, C., & Creatsas, G. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_27 · Cited by 1
Ruokahalun säätely ja lihavuuden lääkehoito : lihavuuslääkkeiden tehoseulontamenetelmä seeprakalalla
Heine, S. (2014) · Helda - University of Helsinki Institutional Repository
Interventiestrategieën bij overgewicht
Mathus-Vliegen, E. M. H. (2004) · Bijblijven · doi:10.1007/bf03059809
Assessment and Treatment of Excess Weight
Turk, M. T. (2011) · Springer eBooks · doi:10.1007/978-3-642-20113-4_5 · Cited by 1
Tuah, A. H. M. (2011) · Spiral (Imperial College London) · doi:10.25560/24932
Risk Factors and Prevention, Including Hyperlipidemia
Gotto, A. M., & Farmer, J. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6705-2_23
The battle against obesity : a role for thermogenic and satiating food ingredients
Diepvens, K. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20071102kd
Tratamiento farmacológico de la obesidad
Cunill, J. L. P., & Jiménez, R. (2005) · Revista Clínica Española · doi:10.1157/13074165
Evidence-Based Health Care in Pediatrics
Robertson-Malt, S. (2014) · Nursing Clinics of North America · doi:10.1016/j.cnur.2014.08.005
Mahmood, M., Muqueet, M., Hoque, M. H., Zaman, S. M., Rahman, M. M., Habib, A., Salim, M. A., Islam, S., Banarjee, S., & Siddique, M. A. (2012) · University Heart Journal · doi:10.3329/uhj.v7i1.10207
Review: Pharmacotherapy as part of a weight management programme: a UK perspective
Barnett, A. H. (2007) · The British Journal of Diabetes · doi:10.1177/14746514070070060301
Metabolic and bariatric surgery for Type 2 diabetics with BMI <35: the time is now
Scharf, K. R., & Morton, J. M. (2014) · Diabetes Management · doi:10.2217/dmt.14.36
Modulació farmacològica de l'oleoil-estrona sobre la ingesta i la composició corporal
Lorente, R. F. (2007) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Avendaño, M., Mackenbach, J. P., & Mc, E. (2006)
Impact of Orlistat on Body Weight and Lipid Profile of Adult Population
Shams, R. M., Saleh, M. A., Abdelrahim, M. E. A., & Mohamed, A. S. E. D. (2012)
Brethauer, S. A. (2013)
Kushner, R. F. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50040-8
Pharmacologic Therapy for Obesity and Overweight in Adults and Adolescents
Aronne, L. J., & Thearle, M. S. (2006) · CRC series in modern nutrition science · doi:10.1201/9781420004649.ch6
BARIATRIC SURGERY; RISK AND BENEFIT
Merdan, I. (2007) · Basrah Journal of Surgery · doi:10.33762/bsurg.2007.56197
Barb, D., Shetty, G. K., & Mantzoros, C. S. (2006) · Humana Press eBooks · doi:10.1007/978-1-59259-985-1_29
Stabb, K. (2017) · Memorial University Research Repository (Memorial University)
Wo, R. (2003) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 1
Obesity and schizophrenia: New drugs, new hopes
Miljević, Č., & Vuković, O. (2020) · Psihijatrija danas · doi:10.5937/psihdan2001113m
Vooruitgang in de klinische praktijk
O’Brien, P. E. (2011) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-011-0002-y
Risk Factors and Prevention, Including Hyperlipidemias
Gotto, A. M., & Farmer, J. A. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-918-9_23
Weight loss methods and diet history among bariatric surgery candidates
Guilbert, L., Sahagún, C. M. V., Guerrero, E., Licona, C. G. C., Escobedo, S. U. P., & Zerrweck, C. (2022) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20221173
USE OF PHARMACOTHERAPY FOR WEIGHT LOSS
(2011) · Nutrition & Dietetics · doi:10.1111/j.1747-0080.2011.01523.x
Smith, S. R. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_15
Orlistat for the prevention of cardiovascular diseases in overweight or obese individuals
Nkansah, N., Garala, M., & Bero, L. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006692.pub2
Halford, J. C. G. (2010) · Springer eBooks · doi:10.1007/978-3-540-68706-1_110
Schurman, L., González, C. D., Leiderman, S. M., Calvar, C. E., Curriá, M., Fernández, G. I., Otta, C. F., & Llano, M. (2016) · Revista Argentina de Endocrinología y Metabolismo · doi:10.1016/j.raem.2016.05.008 · Cited by 2
(2005) · BMJ · doi:10.1136/bmj.331.7529.1390-a
Rang, H. P., Dale, M. M., Ritter, J. M., Flower, R. J., & Henderson, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-3471-8.00031-7
Halford, J. C. G. (2015) · Springer eBooks · doi:10.1007/978-3-642-36172-2_110
SIBUTRAMINE: THE MAGIC PILL TO LOSE WEIGHT AND INCREASE CARDIOVASCULAR RISKS
Amorim, V. E. M., Santos, A. C. B. C., Filho, D. S., da Silva, F. S., Aureliano, P. C. A., Saraiva, M. B. B., de Martino, V., dos Santos, I. L., Brito, T. M., da Silva, G. J., et al. (2023) · International Journal of Health Science · doi:10.22533/at.ed.1593262310048
ANTILIPASE ACTIVITY AND CHEMICAL CONSTITUENTS OFSolanum aculeatissimum Jacq. FRUITS
Megwee, W. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1349
Introduction to Obesity and Anti-obesity Medications
Garcha, S. C., & Kalra, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-1651-0_1
Fixed Combination Anti-obesity Medications
Garcha, S. C., & Kalra, S. (2025) · Springer eBooks · doi:10.1007/978-981-96-1651-0_3
Bressan, C. A. (2023) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
CHOLELITHIASIS FOLLOWING BARIATRIC SURGERY: A NEW APPROACH TO DEAL WITH
Al-Helfy, S. H. A., Almayah, Q. S., & Allami, R. H. (2017) · Iraqi journal of Medical Sciences · doi:10.22578/ijms.15.2.6
Foucault, A. (2012) · theses.fr (ABES) · doi:10.70675/fdfd562bz3291z4465zac18z34fc59162e48 · Cited by 2
Lorcaserin and the Role of 5-HT2C Agonism in the Treatment of Obesity
(2011) · Clinical Medicine Reviews in Therapeutics · doi:10.4137/cmrt.s5768 · Cited by 2
Sirois‐Gagnon, D. (2011) · Constellation (Université du Québec à Chicoutimi) · doi:10.1522/030175066 · Cited by 1
Metadata
- Authors
- Padwal, R., Li, S. K., & Lau, D. C. W.
- Affiliations
- University of Alberta Hospital (CA)
- University of Calgary (CA)
- Corresponding author
- Padwal, R
- ORCID
- Venue
- International Journal of Obesity
- Published
- 2003-09-16
- Volume
- 27
- Issue
- 12
- Pages
- 1437-1446
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W2135749311
- Cited by
- 348
- References
- 57
- Citations by year
- 2026: 1 · 2025: 11 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 8 · 2018: 8 · 2017: 9 · 2016: 8 · 2015: 11 · 2014: 13 · 2013: 21 · 2012: 20
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Keywords
- anti-obesity drugs, orlistat, sibutramine, obesity, overweight, weight loss, long-term efficacy, drug safety, gastrointestinal adverse effects, blood pressure, cardiovascular risk
- MeSH terms
- Orlistat, Cyclobutanes, Humans, Lactones, Obesity, Randomized Controlled Trials as Topic, Anti-Obesity Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.